YEAR | COMPANY | POSITION | SALARY | INCREMENT |
---|---|---|---|---|
2024 | Vigil Neuroscience Inc | Independent Director | - | - |
2024 | Q32 Bio Inc. | Independent Director | - | - |
2024 | Entrada Therapeutics Inc | Independent Director | - | - |
2024 | Cullinan Oncology Inc | Director | - | - |
2023 | Vigil Neuroscience Inc | - | 143.8 K | -13.4 % |
2023 | Alaunos Therapeutics Inc | Independent Director | 112.3 K | -32.4 % |
2022 | Alaunos Therapeutics Inc | Independent Director | 166.2 K | -73.0 % |
2022 | Vigil Neuroscience Inc | Independent Director | 166.1 K | - |
2022 | Entrada Therapeutics Inc | Independent Director | 96.9 K | -77.1 % |
2022 | Q32 Bio Inc. | Independent Director | - | - |
2021 | Alaunos Therapeutics Inc | Independent Director | 615.0 K | 9739.2 % |
2021 | Entrada Therapeutics Inc | Independent Director | 422.7 K | - |
2021 | Q32 Bio Inc. | Independent Director | 128.5 K | -41.5 % |
2021 | Vigil Neuroscience Inc | Independent Director | - | - |
2020 | Q32 Bio Inc. | Independent Director | 219.8 K | -5.5 % |
2020 | Alaunos Therapeutics Inc | Independent Director | 6.3 K | - |
2020 | Entrada Therapeutics Inc | Independent Director | - | - |
2019 | Q32 Bio Inc. | Independent Director | 232.6 K | -20.4 % |
2018 | Q32 Bio Inc. | Independent Director | 292.1 K | - |
2017 | Q32 Bio Inc. | Director | - | - |